O
20.06
0.74 (3.83%)
| Previous Close | 19.32 |
| Open | 19.43 |
| Volume | 320,788 |
| Avg. Volume (3M) | 176,614 |
| Market Cap | 355,509,344 |
| Price / Sales | 0.740 |
| Price / Book | 2.07 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2025 - 11 Aug 2025 |
| Profit Margin | -98.73% |
| Operating Margin (TTM) | -54.86% |
| Diluted EPS (TTM) | -28.79 |
| Quarterly Revenue Growth (YOY) | 5.60% |
| Total Debt/Equity (MRQ) | 57.79% |
| Current Ratio (MRQ) | 8.37 |
| Operating Cash Flow (TTM) | -96.05 M |
| Levered Free Cash Flow (TTM) | -56.52 M |
| Return on Assets (TTM) | -17.41% |
| Return on Equity (TTM) | -86.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Outset Medical, Inc. | Bullish | Bullish |
AIStockmoo Score
0.8
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 2.0 |
| Average | 0.75 |
|
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 0.90% |
| % Held by Institutions | 83.27% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| C Worldwide Group Holding A/S | 31 Dec 2024 | 66,670 |
| 52 Weeks Range | ||
| Median | 21.00 (4.69%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| RBC Capital | 21 May 2025 | 21.00 (4.69%) | Hold | 18.60 |
| 08 May 2025 | 14.00 (-30.21%) | Hold | 15.88 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Jun 2025 | Announcement | Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference |
| 03 Jun 2025 | Announcement | Outset Medical Appoints Renee Gaeta as Chief Financial Officer |
| 14 May 2025 | Announcement | Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors |
| 09 May 2025 | Announcement | Outset Medical to Present at RBC Global Healthcare Conference |
| 07 May 2025 | Announcement | Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined |
| 16 Apr 2025 | Announcement | Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025 |
| 18 Mar 2025 | Announcement | Outset Medical Announces One-for-Fifteen Reverse Stock Split |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |